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ABSTRACT 
Endoplasmic reticulum-associated degradation 
(ERAD) plays a critical role for destruction of 
terminally misfolded proteins at the secretory 
pathway. The system also regulates expression 
levels of several proteins such as Pca1p, a 
cadmium exporter in yeast. To gain better insight 
into the mechanisms underlying ERAD of Pca1p 
and other polytopic proteins by the proteasome in 
the cytosol, our study determined the roles for the 
molecular factors of ERAD in dislodging Pca1p 
from the ER. Inactivation of the 20S proteasome 
leads to accumulation of ubiquitinylated Pca1p in 
the ER membrane, suggesting a role for the 
proteasome in extraction of Pca1p from the ER. 
Pca1p formed a complex with the proteasome at 
the membrane in a Doa10p E3 ligase dependent 
manner. Cdc48p is required for recruiting the 
proteasome to Pca1p. While Ufd2p E4 ubiquitin 
chain extension enzyme is involved in efficient 
degradation of Pca1p, Ufd2p-deficient cells did not 
affect formation of a complex between Pca1p and 
the proteasome. Two other polytopic membrane 
proteins undergoing ERAD, Ste6*p and Hmg2p, 
also displayed the same outcomes observed for 
Pca1p. However, poly-ubiquitinylated Cpy1*p, a 
luminal ERAD substrate, was detected in the 
cytosol independent of proteolytic activities of the 
proteasome. These results indicate that extraction 
and degradation of polytopic membrane proteins at 
the ER is a coupled event. This mechanism would 
relieve the cost of exposed hydrophobic domains 
in the cytosol during ERAD. 
 
 
Buildup of misfolded proteins in the 
endoplasmic reticulum (ER) induces the unfolded-
protein response (UPR) to enhance folding 
capacity and reduce new protein synthesis (1-­‐4). 
Terminally misfolded proteins at the secretory 
pathway are targeted to the ubiquitin-proteasome 
dependent removal system, which is known as ER-
associated degradation (ERAD) (3, 5-9). 
Accumulation of misfolded proteins or excess 
turnover is attributed to multiple diseases, such as 
cystic fibrosis, diabetes, and amyotrophic lateral 
sclerosis, as well as Alzheimer’s and Parkinson’s 
diseases (3, 6, 7). 
Several molecular factors involved in ERAD 
have been characterized (10-13). In the yeast 
Saccharomyces cerevisiae, misfolded ER luminal 
proteins and proteins carrying misfolding(s) at the 
transmembrane region(s) are ubiquitinylated by the 
E3 ubiquitin ligase Hrd1p, whereas, proteins 
carrying misfolding(s) at the cytosolic region(s) are 
ubiquitinylated by Doa10p. While these E3 
enzymes display substrate specificity, some 
overlap also has been observed (14-17). In 
congress with the E3 ubiquitin ligases, several 
other components, such as E2 ubiquitin 
conjugating enzymes, E4 ubiquitin extension 
enzymes, and molecular chaperones work for 
recognition and direction of substrates to ubiquitin 
ligases and the proteasome (3, 13, 16). As the 
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proteasome is in the cytosol, ERAD substrates 
must be mobilized from the ER lumen or dislodged 
from the membrane to be destroyed (18). The 
Cdc48p AAA-ATPase (p97 in mammals) is 
thought to provide a primary driving force in the 
process (10, 14, 19). It has been proposed that 
translocation of luminal ERAD substrates to the 
cytosol may occur through a translocon 
(translocation channel) formed with several 
proteins, such as Sec61p (20-28), and E3 ubiquitin 
ligases possessing multi-transmembrane domains 
(e.g., Hrd1p) (29-31). E4 ubiquitin chain extension 
enzymes (e.g., Ufd2p, Hul5p) facilitate ERAD 
through poly-ubiquitinylation (10, 32, 33).  
Despite significant progress in the 
identification and characterization of molecular 
factors involved in ERAD, the mechanisms of how 
proteins in the ER are targeted to the cytoplasmic 
proteasome remained to be elucidated (3, 10, 32). 
Integral membrane proteins might be dislodged 
from the membrane and escorted to the proteasome 
for destruction (10), which requires the cells to 
extract proteins containing hydrophobic regions 
and maintain their solubility in the cytosol. Thus, 
direct loading of full-length substrates or 
fragmented pieces into the proteasome during the 
extraction from the membrane could be a 
mechanism resolving the problem (32).  
Our previous study showed that expression of 
Pca1p cadmium efflux transporter in the yeast S. 
cerevisiae is dependent upon the ERAD pathway 
(34). In the absence of cadmium Pca1p is rapidly 
turned over through a Doa10p and proteasome-
dependent mechanism; however, when cadmium is 
present, Pca1p escapes from ERAD and is secreted 
to the plasma membrane to export cadmium (34, 
35). A degron at the N-terminal cytosolic domain 
is responsible for the ERAD of Pca1p and also 
senses cadmium to rescue Pca1p from ERAD. 
Because of its rapid turnover (T1/2 = <5 min) (34), a 
degron rather than misfolding-dependent ERAD, 
and control of this process by cadmium, Pca1p is a 
unique example among ERAD substrates. 
Moreover, the well-established experimental 
systems in yeast and conserved mechanisms for 
ERAD between yeast and mammals allow Pca1p 
to be a useful model substrate for gaining a better 
understanding of the mechanisms underlying 
ERAD of polytopic membrane proteins.   
Here we characterized the roles for the 
molecular factors involved in dislodging Pca1p 
from the ER for ERAD. Subcellular location, 
physical interaction with the proteasome, and 
turnover rates of Pca1p were determined in yeast 
cells using genetic and biochemical approaches. 
Our data indicates that extraction and degradation 
of Pca1p and two other polytopic membrane 
proteins, Ste6*p and Hmg2p, are coordinated by 
complex formation with the proteasome while they 
reside at the ER membrane. The mechanism is 
likely significant for avoiding the release of 
membrane proteins to the cytosol. 
 
Experimental Procedures  
 
Yeast Strains and Growth Conditions - A 
BY4741 haploid S. cerevisiae strain (MATa 
his3_1, leu2_0, met15_0, ura3_0) and null mutants 
of particular gene(s) including hul5::KanMX6 
(hul5Δ), ufd2::KanMX6 (ufd2Δ), rpn5::KanMX6 
(rpn5Δ), and doa10::KanMX6 (doa10Δ) were 
obtained from OpenBiosystems. A pdr5::KanMX6 
(pdr5Δ) strain background was used for 
experiments in which cells were co-cultured with 
cycloheximide, MG132, or bortezomib. Strains of 
doa10::His3 or ufd2::His3 in pdr5Δ background 
were generated by homologous recombination of a 
deletion cassette as previously described (36). 
 Yeast cells were cultured in synthetic 
complete (SC) medium [2 % (v/v) dextrose, 0.2 % 
(v/v) amino acid mixture, and 0.67 % (v/v) yeast 
nitrogen base] lacking specific amino acid(s) if 
plasmid selection is necessary. Cells were cultured 
at 30 oC unless specified.  
To inactivate Cdc48p and Cim3p, strains 
expressing a temperature-sensitive CDC48 (cdc48-
3) or CIM3 (cim3-1) allele were cultured at 
permissive temperature (23 oC) and then shifted to 
restrictive temperature (37 oC) for 30 min (37, 38).  
To inhibit translation, cells at the mid-log 
phase were co-cultured with cycloheximide (CHX) 
(Sigma, 100 µg/mL) for a period as indicated in 
each experiment. To inhibit the proteasome, cells 
were co-cultured with MG132 (Cayman Chemical, 
20 µM) (39) or bortezomib (Selleck Chemicals, 20 
µM) (40) for 2 hrs. 
Plasmid Construction - A single copy yeast 
vector p416-GPD (41) was used for 
glyceradehyde-3-phosphate dehydrogenase gene 
promoter-mediated constitutive expression of 
PCA1, N-terminal truncated PCA1 (35), CPY1*, 
STE6* and HMG2. Plasmids for hemagglutinin 
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(HA) epitope tagging and green fluorescent protein 
(GFP) fusion at the N-terminus of Pca1p were 
conducted as previously described (35).  C-
terminal c-myc epitope tagging of Pca1p was 
achieved by PCR cloning using a primer 
containing c-myc sequence prior to the stop codon. 
Cpy1*p possesses the G255R substitution to be 
targeted to ERAD (13). Site-directed mutagenesis 
was accomplished by a primer overlap extension 
method (42). Two c-myc epitopes were inserted in 
the C-terminus of CPY1* for Western blotting 
analysis using anti-myc antibodies. HMG2 
containing one c-myc epitope (43) was subcloned 
in p416-GPD vector. Common molecular biology 
techniques, including plasmid amplification using 
Escherichia coli and purification, followed 
previously established methods (77). Plasmid 
transformation into yeast was performed using the 
lithium acetate method (44). 
Fluorescence Microscopy - Cells cultured in 
SC media were mixed with phosphate-buffered 
saline (PBS) containing NaN3 (15 mM) and NaF 
(15 mM) to inactivate cells. Cells were collected 
by centrifugation and subjected to confocal 
microscopy (Olympus FV500) as described (35).  
Fractionation of Cell Lysates - Yeast cells 
were broken by vortexing (1 min, 5 times) with 
glass beads in the PBS lysis buffer containing 1 
mM phenylmethanesulfonyl fluoride (PMSF), 5 
mM ethylenediaminetetraacetic acid (EDTA), and 
50 mM protease inhibitor cocktail (HaltTM, Thermo 
Scientific). Centrifugation (4 oC, 1,000 x g, 10 
min) removed large cell debris and unbroken cells. 
Soluble and membrane-associated proteins were 
separated by centrifugation (4 oC, 100,000 x g, 1 
hr).  
To differentiate membrane association vs 
membrane integration of Pca1p, membrane 
fractions of prd5Δ, cdc48-3 (cultured at 37 oC), 
and doa10Δ cells expressing 3HA epitope-tagged 
Pca1p were re-solubilized in phosphate-buffered 
saline (PBS) with and without Na2CO3 or Triton 
X-100.  After incubation at 4 oC for 30 min, 
samples were fractionated by centrifugation (4 oC, 
100,000 x g, 30 min). Supernatant (S) was 
precipitated using Trichloroacetic acid (TCA) and 
denatured in SDS sample buffer. The un-soluble 
pellet (N) was denatured in SDS sample buffer. 
Both S and N samples were subjected to Western 
blot analysis.  
Flotation sucrose gradient fractionation was 
performed as previously described (45). Yeast cells 
were broken using glass beads in the lysis buffer 
(50 mM HEPES, 150 mM NaCl, 5 mM EDTA, 1 
mM dithiothreitol (DTT), 1 mM PMSF, 50 mM 
protease inhibitor cocktail). Sucrose gradient [0.25 
M, 1.5 M, ~1.7 M (mixture of 200 µl cell lysate 
and 600 µl 2.3 M sucrose), and 2.3 M in 
descending order] was spun at 4 oC at 100,000 x g 
for 5 hrs.  Twelve fractions (300 µL each) were 
then taken from the top. 
In vitro De-ubiquitinylation - The flotation 
sucrose gradient fractions (10-12) were subjected 
to buffer exchange using Slide-A-Lyzer dialysis 
cassette (Thermo Scientific) in 500 mL of de-
ubiquitinylation buffer (50 mM HEPES, 150 mM 
NaCl, 5 mM EDTA, 1 mM DTT, 1 mM PMSF, 
protease inhibitor cocktail without sucrose), 
followed by incubation with 5 ng of USP2 catalytic 
domain (BML-UW9850-0100 Enzo-life sciences) 
rocking at 37 oC for 1 hr.  Samples were then 
subjected to a second round of buffer exchange in 
the same buffer without DTT.  Immuno-
precipitation was conducted using a kit 
(ProfoundTM c-Myc Tag IP/Co-IP application set, 
Thermo Scientific) according to the manufacturer’s 
specifications.  
In Vivo Cross-linking and Immuno-
precipitation - Cells expressing Pca1p tagged with 
HA epitope were co-cultured with a 20S 
proteasome inhibitor MG132 (20 µM, 2 hrs). Cells 
were collected by washing twice in ice-cold PBS 
and re-suspended in PBS containing MG132 and a 
membrane permeable thiol-reversible cross-linker, 
dimethyl 3,3’-dithiobispropionimidate (DTBP) 
(100 µg/ml final concentration), for 30 min at room 
temperature with gentle rocking.  Cells were then 
washed in the lysis buffer [50 mM Tris-HCl (pH 
7.4), 5 mM EDTA, 50 mM protease inhibitor 
cocktail, and 1 mM PMSF] to quench crosslinking 
reaction. Cells were then broken by glass bead 
disruption (10 x 1 min on ice). Lysates were 
collected and fractionated by centrifugation 
(100,000 x g, 30 min). The resulting pellet was 
washed twice in ice-cold PBS and re-suspended in 
PBS containing Triton X-100 (1 %, v/v) and 
protease inhibitors. Immuno-precipitation was 
performed using a kit (ProfoundTM c-Myc Tag 
IP/Co-IP application set, Thermo Scientific) 
according to the manufacturer’s specifications. 
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DTT in the SDS sample buffer cleaved the 
crosslinks.   
Immunoblotting - Yeast cells were broken by 
vortexing (5 x 1 min) with glass beads in the lysis 
buffer (PBS containing 1 mM PMSF, 50 mM 
protease inhibitor cocktail, 5 mM EDTA, 1% 
Triton X-100). Soluble fraction was obtained by 
centrifugation (21,000 x g, 15 min). Protein 
concentrations were measured using a kit (BCA, 
Pierce) according to the manufacturer’s 
specifications. Samples were denatured in a 
reducing SDS sample buffer containing 
dithiothreitol (DTT, 25 mM) for 15 min at 37 °C 
and then subjected to polyacrylamide gel 
electrophoresis (PAGE). This mild denaturation 
condition avoided aggregation of Pca1p which 
contains eight predicted transmembrane helixes. 
Gels were transferred to nitrocellulose membrane 
and hybridized with primary antibodies against HA 
epitope (Rockland, 600-401-384), Rpn5p subunit 
of the 19S proteasome (Abnova, PAB 15594), α 
and β subunits of 20S proteasome (Abcom, 
ab22673), c-myc epitope (ABM, G019), or 
ubiquitin (Covance, MMS-257P). 3-
phosphoglycerate kinase (Pgk1p) was detected 
using anti-Pgk1p antibodies (Invitrogen, 459250) 
to determine equal loading. Horseradish 
peroxidase-conjugated goat anti-rabbit IgG or 
sheep anti-mouse IgG (Santa Cruz Biotechnology 
Inc) was used as secondary antibodies. Western 
Pico Chemiluminescence (Pierce) was used to 
detect antibody bound proteins.  
Statistical Analysis - Experiment were 
conducted using minimum two independent clones, 
and representative data was presented. Results 
were presented as means ± SD. Student's t-test 
determined the statistical differences. P < 0.05 was 
considered to be significant. 
 
Results 
 
 Pca1p remains in the membrane when the 
proteasome is inactivated – Pca1p, a cadmium-
exporting P1B-type ATPase in yeast, is a polytopic 
protein (Fig. 1A) that undergoes ERAD in the 
absence of cadmium (34). A degron identified 
within amino acids 250 and 350 at the N-terminal 
cytosolic domain (1-557 amino acids, ~61 kDa) 
(Fig. 1A), Doa10p, an E3 ligase, and the 
proteasome are required for Pca1p turnover (35). 
Given cadmium-induced rescue of Pca1p from 
ERAD (34, 35) and its eight predicted 
transmembrane helices, we sought to determine if 
ERAD of Pca1p relies on known molecular factors 
for ERAD of misfolded proteins and how this 
polytopic protein is degraded by the proteasome. 
To determine subcellular localization and turnover 
rates of Pca1p, we fused green fluorescent protein 
(GFP) or epitope, such as triple hemagglutinin 
(3HA) and two c-myc (2Myc) at the N- or C-
terminus (Fig. 1A). These PCA1 alleles are fully 
functional and display cadmium-dependent ERAD 
(data not shown). 
We first determined subcellular distribution of 
GFP-Pca1p when proteolytic activities of the 
proteasome are inhibited by MG132 co-culture 
(46) or Cdc48p AAA-ATPase is inactivated (Fig. 
1B). Cdc48p is a known critical player in 
dislodging ERAD substrates from the ER (47). A 
strain possessing temperature-sensitive CDC48 
allele (cdc48-3) was used to inactive this essential 
gene (37) at a restrictive temperature, 37 oC. Cells 
were pre-cultured with cycloheximide to inhibit 
new Pca1p synthesis. Pca1p fused with GFP at the 
N-terminus (GFP-Pca1p) is not detectable in wild 
type (WT) control cells because of rapid turnover 
as demonstrated previously (35); however, Pca1p 
is highly expressed when the proteasome or 
Cdc48p is inactivated (Fig. 1B). Co-localization of 
Pca1p-GFP with Sec63p, an ER resident protein, 
indicates that Pca1p remains in the ER membrane 
under the experimental conditions. These results 
suggest that ubiquitinylated Pca1p cannot be 
extracted from the ER membrane without 
proteolytic activities of the proteasome or upon 
inactivation of Cdc48p AAA-type ATPase.     
We next ascertained cellular levels of Pca1p 
and its fragments when the proteasome or Cdc48p 
is inactivated. Pca1p fused with 3HA and 2Myc 
(Fig. 1A) was expressed in WT, cdc48-3, and 
doa10Δ cells. Western blotting analyses of cell 
lysates using anti-HA or c-myc antibodies 
displayed signals at the locations corresponding to 
full-length Pca1p (the triangle in Fig. 1C). Given 
that the half-life of Pca1p is less than 5 min (35), 
the majority of remaining Pca1p in wild-type (WT) 
cells co-cultured with cycloheximide should be 
ubiquitinylated species. Pca1p fragments below 
full-length Pca1p, including approximately 60, 70, 
75, and 90 kDa bands, were detected in WT, 
cdc48-3, and doa10Δ cells (Fig. 1C, upper panel). 
We previously reported that Pca1p ubiquitinylation 
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is absent in doa10Δ cells (34, 35). Therefore, 
fragmentation of Pca1p, observed in doa10Δ cells, 
is unlikely a ubiquitinylation-dependent process. 
When probing with anti-myc antibodies, only full 
length was detectable and all lower molecular 
weight fragments were non-specific as seen by the 
empty vector control (Fig. 1C, middle panel, lane 
1). To determine distribution of Pca1p, total cell 
lysates were fractionated by ultra-centrifugation 
(100,000 x g for 30 min) to supernatant (S) and 
pellet (P) containing soluble proteins and 
membranes, respectively (Fig. 1D). Western blot 
analysis detected full-length and higher molecular 
weight Pca1p species at the “P” fraction but not 
“S” fraction (Fig. 1D). Immuno-precipitation of 
Pca1p from the “S” and “P” fractions with anti-HA 
antibodies followed by Western blotting using anti-
HA and -ubiquitin (Ub) antibodies (Fig. 1E) 
further suggested that most ubiquitinylated Pca1p 
species, except a potion of the ~75 kDa fragment, 
reside in the membrane.  
To rule out any off-target effect of MG132 on 
proteasome inhibition, we also conducted the 
experiments using another proteasome inhibitor, 
bortezomib (40), and a strain expressing a 
temperature-sensitive allele of CIM3 (cim3-1), 
encoding a proteasome subunit (38). Fluorescent 
confocal microscopy of cells co-cultured with 
bortezomib displayed virtually identical results 
obtained using MG132. However, cells expressing 
CIM3-1 manifested Pca1p stabilization at the ER at 
both permissive (23 oC) and restrictive (37 oC) 
temperature (data not shown), which was 
confirmed by Western blot analysis (Fig. 1F, 4th 
lane vs 5th lane). This indicates that Cim3-1p is not 
fully functional at both 23 and 30 oC. Fractionation 
of soluble and membrane proteins followed by 
Western blotting of Pca1p also displayed similar 
results between bortezomib and MG132 co-
cultures (Fig. 1G).  
Collectively, the data presented in Fig. 1 
suggests that most Pca1p and its fragments, except 
for a ~60 kDa fragment, are not dislodged from the 
membrane without the activities of the proteasome 
and Cdc48p.  
Pca1p in the pellet fraction exists as 
membrane-integrated species – We next 
considered the possibilities that Pca1p could be 
extracted out of the lipid bilayer but attached to the 
membrane or form large cytosolic complexes that 
could be pulled down to the pellet fraction. To 
address these concerns, the membrane fractions 
were incubated with Na2CO3 (0.2 M, pH 11) (48) 
to release peripheral membrane proteins to 
supernatant (S) (Fig. 2A). However, all Pca1p 
species, including Pca1p fragments that migrate 
faster than full-length Pca1p, remain in the non-
soluble pellet (N) factions of WT cells co-cultured 
with MG132 (Fig. 2A, left panel). Na2CO3 
dissociates only a small potion (< 5 %) of full-
length and fragmented Pca1p from the membrane 
(Fig. 2A, left panel, 3rd lane). Only a small portion 
of Pca1p detected in the membrane fraction was 
dissociated by Na2CO3 in Cdc48p-inactive cells 
and in doa10Δ cells (Fig. 2A, middle and right 
panels), indicating membrane integration of Pca1p 
species. Triton X-100 (1 %, v/v) released Pca1p to 
the “S” fraction near completely (Fig. 2A), 
suggesting that most Pca1p and its fragments are 
integrated in the membrane.  
To confirm Pca1p’s localization in the 
membrane rather than aggregated complexes, cell 
lysates were subjected to a sucrose density gradient 
fractionation (45) (Fig. 2B). If Pca1p is in 
membrane vesicles, it will “float” to the low-
density fractions. WT cells expressing 3HA-tagged 
Pca1p or Pca1p(degronΔ) lacking first 392 amino 
acids containing the degron were co-cultured with 
MG132 for 2 hrs. Glass bead-disrupted cells were 
loaded at the layer of 1.7 M sucrose. 
Centrifugation followed by Western blotting 
analysis of collected fractions displayed that the 
majority of full-length Pca1p and Pca1p(Δ392) are 
within the membrane-containing low density 
fractions, unlike Pgk1p, a soluble protein (Fig. 2B, 
4th panel). Membrane solubilization of cell lysate 
with Triton X-100 (1 %, v/v) resulted in co-
fractionation of Pca1p with Pgk1p (Fig. 2B, 3rd 
panel).  
Pca1p species with different degrees of 
ubiquitinylation may exist in the cytosol below 
detectable limit by Western blot. To address this 
concern, we assessed the ubiquitinylation status of 
Pca1p in the fractions 10, 11 and 12 containing 
soluble proteins. Pca1p was immuno-precipitated 
using anti-HA antibodies and then probed with 
antibodies against ubiquitin and HA epitopes (Fig. 
2C). The soluble protein fractions contain three 
major ubiquitin-conjugated Pca1p fragments (~60, 
~75, and ~90 kDa) (Fig. 2C, 1st panel). It was 
further determined that poly-ubiquitinylated full-
length Pca1p species were not present in the 
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soluble fractions since deubiquitinylation by the 
purified catalytic subunit of the de-ubiquintylating 
enzyme, USP2, did not lead to an enrichment of 
full-length Pca1p (Fig. 2C, 2nd panel). Anti-HA 
antibodies detected primarily a fragment of ~60 
kDa. Given the predicted N-terminal cytosolic 
domain (61 kDa + ~3 kDa corresponding to tagged 
3HA epitopes), the ubiquitinylated Pca1p fragment 
detected in the soluble fraction could be a cleaved 
N-terminal cytosolic domain. However, a portion 
of the fragment is also detected in the membrane 
fraction as a peptide integrated into membrane 
(Figs. 1D, 1G, 2A, and 2B). Therefore, it is likely 
that the fragment contains one or more trans-
membrane helixes (Fig. 1A) and/or domain(s) 
incorporated into the lipid bilayer.  
Collectively, these results indicate that in the 
absence of proteasomal activities, Pca1p and most 
of its fragments, except for the ~60 kDa fragment, 
are not dislodged from the membrane.   
Pca1p interacts with the proteasome at the ER 
membrane in an E3 ligase and a degron dependent 
manner – Given the potential role for the 
proteasome in extraction of Pca1p from the ER, we 
next determined if the proteasome forms a 
complex with Pca1p at the ER membrane. WT and 
doa10Δ cells expressing C-terminal two c-myc 
epitope-tagged wild-type control Pca1p and Pca1p 
lacking N-terminal 392 amino acids which 
contains a degron [Pca1(degronΔ)] were co-
cultured with MG132 to inactivate the 20S 
proteasome. Membrane fractions were isolated as 
described in Fig. 1D, washed, and solubilized 
[Triton X-100, 1 % (v/v)]. Samples were then 
subjected to immuno-precipitation of Pca1p. the 
formation of a complex between Pca1p and Rpn5, 
a proteasome subunit (49), was visualized by 
Western blot. However, no detectable association 
was observed without cross-linker co-culture (Fig. 
3A, lane 3). This could reflect a transient binding 
between Pca1p and the proteasome in the process 
of degradation. To address this concern, we 
conducted the experiment using a membrane 
permeable thiol–reversible cross-linker, dimethyl 
3,3'-dithiobispropionimidate (DTBP). After 
breaking cross-links by denaturing samples in 
dithiothreitol-containing SDS sample buffer, 
physical interactions of proteasome subunits (46) 
with Pca1p were visualized by Western blotting. 
Indeed, Pca1p was found to form a complex with 
Rpn5p, a 19S proteasomal subunit (Fig. 3A, lane 4; 
Fig. 3C, lane 2), and the α and β subunits of 20S 
proteasome (Fig. 3D) at the membrane. While 
immuno-precipitation efficiency of Pca1p was over 
90 % (Fig. 3B, 1st panel, lane 2 vs 4), most Rpn5p 
(>81%) still remained in the flow-through (Fig. 
3B, 2nd panel, lane 2 vs 4). This suggests that 
Rpn5p is associated with not only Pca1p but also 
other membrane proteins. 
The complex formation between Pca1p and 
Rpn5p was dependent on Doa10p and the degron 
in Pca1p (Fig. 3C). Although expression levels of 
Pca1p in doa10Δ cells and Pca1p lacking the 
degron [Pca1p(degronΔ)] were strikingly higher 
than Pca1p levels in wild-type control cells (Fig. 
3C, lane 3) (34, 35), immuno-precipitation of 
Pca1p and Pca1p(degronΔ) in doa10Δ and WT 
cells, respectively, did not pull down Rpn5p at 
detectable levels (Fig. 3C, middle panel). These 
results confirm the specificity in the complex 
formation between Pca1p and Rpn5p and indicate 
that when Pca1p is ubiquitinylated by Doa10p, the 
proteasome is recruited while Pca1p resides at the 
membrane.  
Cdc48p is required for the complex formation 
between Pca1p and the proteasome – Cdc48p is a 
critical molecular factor for ERAD of Pca1p (Figs. 
1, 2A, 4A) and other proteins (10, 34, 37). ATPase 
activities of Cdc48p are believed to contribute to 
the retro-translocation of ubiquitinylated luminal 
proteins for ERAD (37), and Cdc48p may escort 
them to the proteasome as demonstrated by a 
physical interaction between Cdc48p and the 
proteasome (37).  To determine the role of Cdc48p 
in the ERAD of Pca1p in conjunction with the 
interaction between Pca1p and the proteasome, we 
ascertained if the proteasome forms a complex 
with Pca1p in the cells expressing inactive Cdc48p. 
The levels of ubiquitinylated proteins in the cells 
expressing non-functional Cdc48p (37 oC culture) 
are comparable (1.26 ± 0.62 fold, n=3, p=0.53) to 
those of control (23 oC culture) cells  (Fig. 4A, 
upper panel). Despite higher Pca1p expression in 
Cdc48p-defective cells (Fig. 4A, 2nd panel), 
immuno-precipitation of Pca1p followed by Rpn5p 
detection revealed that formation of a complex 
between Pca1p and the proteasome is dramatically 
reduced in cells expressing non-functional Cdc48p 
(Fig. 4B). This result suggests that Cdc48p 
recognizes ubiquitinylated Pca1p for recruitment to 
the proteasome.  
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It was known that Cdc48p also interacts with 
other molecular factors involved in ERAD such as 
E4 ubiquitin chain extension enzyme (50). The 
observed defect of Pca1p ERAD (Fig. 1B) and the 
lack of Pca1p interaction with the proteasome (Fig. 
4B) in the cells expressing non-functional Cdc48p 
may be attributed to a deficiency in recruiting E4 
ligase(s) and/or presenting mono-ubiquitinylated 
Pca1p for polyubiquitination. To address this, we 
determined ubiquitinylation status of Pca1p in 
Cdc48p inactive cells. Immunoprecipitation of 
Pca1p using anti-HA antibodies followed by 
Western blot analysis of Pca1p using anti-ubiquitin 
antibodies determined poly-ubiquitinylation of 
Pca1p in the cells expressing non-functional 
Cdc48p (Fig. 4C). Given that Pca1p levels in cells 
expressing nonfunctional Cdc48p are 5-fold higher 
relative to those in control cells (Fig. 4A and 4B), 
for the experiment presented in Fig. 4C, we loaded 
5-fold higher immuno-precipitated sample 
obtained from cells cultured at 23 oC. Our data 
displayed that the cells expressing non-functional 
Cdc48p accumulate poly-ubiquitinylated Pca1p 
comparable to control cells (Fig. 4C). Therefore, 
the higher Pca1p expression (Fig. 4A, 2nd panel) 
and the reduced association of Pca1p with the 
proteasome (Fig. 4B) in Cdc48p-inactive cells are 
unlikely attributed to a defect in poly-
ubiquitinylation of Pca1p. 
Ufd2p, an E4 Ubiquitin Extension Enzyme for 
Pca1p, and poly-ubiquitinylation of Pca1p did not 
affect complex formation between Pca1p and the 
proteasome – Following ubiquitinylation by E3 
ligase(s), E4 ubiquitin chain extension enzymes, 
such as Ufd2p and Hul5p in yeast, have been 
implicated in the degradation of several ERAD 
substrates (10, 32, 50, 51). Ufd2p interacts with 
Cdc48p and Rad23p in the process of substrate 
delivery to the proteasome (28). It is intriguing that 
Ufd2p regulates turnover of only a subset of 
Doa10p substrates (33), and Hul5p has been found 
to be associated with the 19S proteasome (32, 52, 
53). We determined the half-life (T1/2), poly-
ubiquitinylation of Pca1p, and formation of a 
complex between Pca1p and the proteasome in 
ufd2Δ and hul5Δ strains. Cycloheximide chase of 
Pca1p revealed no significant difference in Pca1p 
degradation in WT and hul5Δ cells; however, 
UFD2 deletion dramatically extended T1/2 of Pca1p 
(Figs. 5A and 5B). This result suggests that Ufd2p 
is required for efficient turnover of Pca1p. 
Immuno-precipitation of Pca1p followed by 
immunoblotting using anti-ubiquitin antibodies 
supported that Ufd2p is the major E4 enzyme of 
Pca1p (Fig. 5C). In the ufd2Δ cells, most Pca1p 
species were detected at the membrane 
fractionation but not at the soluble fraction (Fig. 
5D) indicating that in the ufd2Δ cells, the majority 
of Pca1p remains in the membrane. 
 As Ufd2p is required for efficient degradation 
of Pca1p (Fig. 5B), we next sought to determine if 
poly-ubiquitinylation by Ufd2p is necessary for the 
interaction of Pca1p with the proteasome. In vivo 
cross-linking and co-immunoprecipitation 
followed by Western blot analysis showed that 
Pca1p is still able to interact with the proteasome 
in the absence of Ufd2p (Fig. 5E). This indicates 
that Ufd2p-dependent ubiquitin chain extension 
(Fig. 5C) is not critical for formation of a complex 
between Pca1p and the proteasome. This result 
also further confirmed that the reduced interaction 
of Pca1p with the proteasome in cells expressing 
nonfunctional Cdc48p (Figs. 4B and 4C) is not 
relevant to poly-ubiquitinylation status of Pca1p. 
Proteasome dependent extraction of ERAD 
substrates is specific for polytopic proteins – We 
next determined if other poly-topic membrane 
proteins undergoing ERAD manifest an interaction 
with the proteasome at the membrane as observed 
for Pca1p. Ste6*p is a mutated form of the alpha 
factor transporter Ste6p in yeast (54), which causes 
a premature stop codon and a change in N-
glycosylation. Ste6*p is also targeted for 
degradation via Doa10p, Cdc48p, and proteasome 
dependent pathway (10, 54, 55). Subcellular 
fractionation and flotation sucrose gradient 
fractionation showed that Ste6*p remained in the 
membrane fraction under proteasome inhibition 
conditions (data not shown) as observed for Pca1p. 
The same experiment described in Fig. 3A showed 
that Ste6*p pulled down a proteasome subunit 
Rpn5p in a Doa10p-dependendent manner (Fig. 
6A). Therefore, Ste6*p also interacts with the 
proteasome at the ER membrane when it is 
ubiquitinylated by Doa10p. 
 The expression of Hmg2p, an ER-resident 
membrane enzyme required for cholesterol 
synthesis, is controlled through the ERAD-M 
pathway. When the proteasome is inactivated by 
MG132 co-culture, Hmg2p also forms a complex 
with the proteasome at the membrane and not in 
the cytosol (Fig. 6B). Therefore, as observed for 
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Pca1p and Ste6*p, inhibition of proteolytic 
function of the proteasome prevents Hmg2p 
release from the ER membrane.   
 Vacuolar carboxypeptidase Y (Cpy1p) 
containing a G255R mutation (Cpy1*p) is 
degraded through the ERAD-C pathway (13, 56-
59). We have employed Cpy1*p as an example of 
an ER luminal protein to elaborate the hypothesis 
that soluble ERAD substrates may be retro-
translocated prior to being targeted to the 
proteasome. When WT yeast cells expressing c-
myc epitope tagged Cpy1*p were co-cultured with 
MG132, a proteasome inhibitor, Cpy1*p was 
detected as full-length and poly-ubiquitinylated 
forms in the soluble (S) fraction (Fig. 6C). Rpn5p, 
a subunit of 19S proteasome, was co-
immunoprecipitated with Cpy1*p in soluble 
fraction (Fig. 6C, 2nd panel) indicating that 
Cpy1*p forms a complex with the proteasome in 
the cytosol. However, Cpy1*p in the cells lacking 
Hrd1p E3 ligase targeting Cpy1*p for ERAD 
remains at the pellet fraction along with Kar2p, an 
ER luminal protein (Fig. 6D); therefore, detection 
of Cpy1*p in soluble fraction (Fig. 6C) is a 
consequence of ERAD progress of Cpy1*p rather 
than its leaking from the ER during sample 
preparation followed by interaction with the 
proteasome. These results suggest that Cpy1*p 
ubiquitinylated by Hrd1p is retro-translocated to 
the cytosol without proteolytic activities of the 
proteasome. This is distinct from other examined 
polytopic proteins, Pca1p, Ste6*p, and Hmg2p.  
 
Discussion 
 
ERAD involves retro-translocation of ER 
luminal proteins and dislodging of membrane 
proteins. Our data suggests that polytopic ERAD 
substrates undergo proteasomal degradation at the 
ER membrane via recruiting the proteasome rather 
than being extracted to the cytosol prior to delivery 
to the proteasome. This is distinct from ERAD of 
Cpy1*p, a soluble protein in the lumen of the ER. 
The coupling of dislodging and destruction of 
membrane proteins would be advantageous for 
cells by minimizing the energy cost associated 
with dealing hydrophobic proteins in the cytosol. 
These results shed new light on this vital but under 
characterized process.  
Cdc48p (p97/VCP in higher eukaryotes), a 
hexameric AAA-type ATPase, plays diverse roles 
in ERAD (60, 61), although the mechanistic details 
remain to be defined.  Despite experimental 
evidence arguing a non-essential role of Cdc48p in 
the ERAD process (62), our study confirmed that 
Cdc48p is a significant player for ERAD of Pca1p 
by promoting its binding to the proteasome. In 
cells expressing inactive Cdc48p, the complex 
formation between the proteasome and Pca1p and 
Pca1p degradation is impaired. This result is 
consistent to a previous report displaying a 
cooperation between Cdc48p and the proteasome 
in turnover of Insig-1p, an ERAD-M substrate 
(63). Several lines of evidence support that Cdc48p 
and its cofactors, Ufd1p and Npl4p, are recruited to 
the ER via Ubx2p to disassemble ubiquitin-
conjugated substrates from the membrane and for 
the delivery of those to the proteasome (60, 61). 
Therefore, it is likely that Cdc48p facilitates the 
interaction between ubiquitinylated Pca1p and the 
proteasome.  
Distinct from the ERAD-L pathway dealing 
with soluble substrates, a concern in ERAD of 
integral membrane proteins (ERAD-M and -C 
pathways) would be the extraction of proteins from 
the lipid bilayer and solubilization at the cytosol 
(10, 64). While several potential mechanisms have 
been proposed (3, 10, 32), the results reported 
previously were not consistent with each other. An 
in vitro reconstitution assay found that prior to 
degradation, Ste6*p, a well-characterized ERAD-C 
substrate, is dislodged from the membrane (10); 
however, it is worth pointing out that only a small 
fraction of Ste6*p was released from the 
membrane under the experimental conditions. 
Secondly, an in vitro ERAD assay of CFTR 
displayed relatively minor effects of proteasome 
inactivation on extraction and release of its 
degradation intermediates from the ER membrane 
(65). Our study was conducted in cells, and most 
ubiquitinylated Pca1p and its fragments remained 
in the membrane and formed a complex with the 
proteasome. This finding was confirmed with two 
other polytopic proteins. Therefore, our data 
supports the hypothesis that dislodging of 
membrane proteins does not occur prior to their 
delivery to the proteasome.  
Detection of the complex containing Pca1p 
and subunits of 19S and 20S proteasome from the 
membrane fractions is dependent on Doa10p, the 
major E3 ubiquitin ligase of Pca1p. This suggests 
that ubiquitinylated Pca1p attracts the proteasome 
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while residing in the ER membrane. The 
proteasomes are localized mainly in the nucleus 
and cytosol as free or nuclear envelope and ER 
network-attached forms (66-68). The clustering of 
the proteasomes on the ER membrane is 
particularly high in the yeast S. cerevisiae (> 80 % 
total proteasome) relative to mammals (< 20 %) 
(67). The proteasome might be associated with the 
ER via physical interaction with ER membrane 
protein(s), which is reminiscent of Cue1 and 
Ubx2p recruiting Ubc6p/7p and Cdc48p to the ER 
membrane, respectively (71-73). This may allow 
for rapid recognition of ERAD substrates by the 
proteasome. Sts1p is critical for enriching the 
proteasome at the nuclear envelope (70); however, 
the counterpart at the ER membrane remains to be 
identified. Alternatively, the enrichment of the 
proteasome at the ER membrane might reflect the 
complexes between the proteasome and proteins 
undergoing ERAD. High demand of ERAD might 
control the distribution of the proteasomes for an 
efficient completion of the task. The 26S, 20S, and 
19S proteasomal particles are known to exist in a 
dynamic equilibrium (68). The assembly, subunit 
composition, post-translational modifications of 
amino acid residues, and interaction of the 
proteasome with regulators(s) if any, could be 
changed in response to cellular cues and stresses 
(66). It would be interesting to examine if ER 
stresses would lead to an enrichment of the 
proteasomes to the ER membrane. This could be 
better accessed in mammals displaying relatively 
minor steady state ER localization of the 
proteasome (74, 75).  
The significance of polyubiqitinylation of 
membrane proteins in ERAD remains an intriguing 
question. The regulatory particles of the 
proteasome contain several functional components, 
including AAA-Type ATPase, E4 ubiquitin 
ligase(s), and de-ubiquitinylation enzyme(s). 
Hul5p, an E4 enzyme associated with the 
regulatory particle of yeast, is involved in ERAD 
of reporter substrates (e.g., CTL* and Sec61-2L) 
(32) and proteasome-dependent degradation of 
cytosolic proteins that are damaged under heat 
stress (52). However, knockout of UFD2 gene 
encoding another E4 ligase did not affect the heat-
induced ubiquitylation (52). Our study on the 
turnover rate of Pca1p in hul5Δ and ufd2Δ strains 
showed that the Ufd2p but not Hul5p is involved in 
ERAD of Pca1p, confirming target specificity of 
E4 ligases. Nevertheless, it’s worth noting that the 
relative stability of Pca1p in ufd2Δ strain was still 
significantly lower than that of the doa10Δ strain 
(T1/2 = 30 min vs > 2 hrs), which suggests that 
poly-ubiquitinylation is not essential for ERAD but 
enhances the efficiency. One might argue that, 
given three other E4 ligases in addition to Hul5p 
and Ufd2p in the genome of the yeast S. cerevisiae 
(76), there may be some redundancy. However, we 
disproved this by showing near absence of poly-
ubiquitinylated Pca1p in ufd2Δ cells. It is also 
interesting to note that, although Pca1p turnover is 
slow in ufd2Δ cells and a drastic reduction of poly-
ubiquitinylation of Pca1p in the cells, Ufd2p 
deficiency does not affect the formation of a 
complex between Pca1p and the proteasome. 
These results indicate that poly-ubiquitinylation of 
Pca1p is not a critical determinant of initial 
interaction with the proteasome but rather 
promotes efficient processing of substrates by the 
proteasome.  
This study reflects a comprehensive in vivo 
study determining how polytopic proteins are 
targeted to the ERAD pathway in yeast. The 
recruitment of the proteasome to ubiquitinylated 
proteins while they reside in the membrane could 
be a conserved mechanism in ERAD of higher 
eukaryotes. It would be also interesting to define 
whether the proteasome-dependent destruction of 
membrane proteins in other organelles occurs in a 
similar manner.  
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Figure Legends 
 
FIGURE 1. Localization of Pca1p at the membrane of the cells in which the proteasome or Cdc48p 
is inactivated. A, A schematic depiction of Pca1p. The black squares indicate eight trans-membrane 
helixes. Green fluorescent protein (GFP) or triple HA epitope (3HA) is fused at the N-terminus (filled 
oval). Two c-myc epitope (2Myc) is fused at the C-terminus (empty oval). The unfilled square indicates 
the amino acid 250-350 region containing a degron. B, Subcellular distribution of Pca1p determined by 
fluorescent microscopy. Expression plasmids of GFP-fused Pca1p and red fluorescent protein (RFP)-
fused Sec63p, an ER-resident protein, were co-expressed in a control strain lacking PDR5 (WT) and a 
strain containing a temperature-sensitive allele of CDC48 (cdc48-3). Mid-log phase cells were cultured 
with and without MG132 for 2 hrs. Cycloheximide was added to the media 1 hr before collecting cells. 
The cdc48-3 cells cultured at 23 oC were shifted to 37 oC for 30 min. Subcellular distribution of Pca1p-
GFP was visualized by confocal fluorescent microscopy. C, Detection of Pca1p and its fragments by 
immuno-blotting. Pca1p fused with 3HA and 2Myc was expressed in a WT, a strain expressing cdc48-3 
allele, and a doa10Δ strain. WT and cdc48-3 cells were pre-cultured with MG132 for 2 hrs and at 37 oC 
for 30 min, respectively. Total cell extracts prepared by glass bead disruption and Triton X-100 (1 %) 
solubilization were subjected to Western blot using anti-HA and -myc antibodies. The blots were also 
probed with anti-Pgk1p antibodies to determine equal loading. D, Determination of subcellular 
distribution of Pca1p. Lysates of the cells that were cultured as described in C were prepared by glass 
bead disruption followed by removing un-broken cells (300 x g for 10 min centrifugation). The samples 
were separated to soluble (S) and pellet (P) fractions by centrifugation (100,000 x g for 30 min).  The S 
and P fractions were solubilized (1 % Triton X-100) and subjected to Western blot analysis using Anti-
HA antibodies. E, Detection of majority of ubiquitinylated Pca1p at the P fraction. Pca1p in the S and P 
fractions obtained from WT cells as described above was immuno-precipitated using anti-HA antibodies. 
Expression levels and ubiquitinylation status of Pca1p were determined by Western blot using anti-HA 
and -ubiquitin (Ub) antibodies, respectively. F and G, The experiments presented in C and D were 
conducted using bortezomib, a proteasome inhibitor, and a strain carrying a temperature-sensitive cim3-1 
allele. The triangle (C - G), asterisks (C, F, G), and arrows (C, F) indicate the location of full-length non-
ubiquitinylated Pca1p, non-specific bands detected by anti-myc (C) or anti-HA (F) antibodies, and a 
Pca1p fragment dominant in proteasome-inactive WT cells relative to other cells, respectively. Each 
experiment was conducted three or more times using different clones, and representative data is 
presented. 
 
FIGURE 2. Detection of fragmented or ubiquitinylated Pca1p by subcellular fractionation. A, 
Majority of Pca1p and its fragments are embedded in the membrane. Pca1p fused with triple HA at the N-
terminus was expressed in a control strain lacking PDR5 (WT), a strain expressing a cdc48-3 temperature 
sensitive allele, and a doa10Δ strain. WT and cdc48-3 cells were cultured with MG132 (20 µM, 2 hrs) 
and at 37oC (30 min), respectively. Membrane fractions obtained by centrifugation (100,000 x g, 30 min) 
of total cell lysate were re-suspended in phosphate-buffered saline (PBS) with and without Na2CO3 (0.2 
M, pH 11) or Triton X-100 (1 %). The samples were incubated for 30 min on ice and then centrifuged at 
100,000 × g for 30 min. The supernatant (S) was precipitated in trichloroacetic acid (10 %) and washed 
twice with acetone. The nonsoluble pellet (N) was re-suspended in PBS containing detergent (1 % Triton 
X-100). Samples were denatured in SDS sample buffer (37 oC, 15 min) and analyzed by Western blot 
using anti-HA antibodies. B, Fractionation of Pca1p by flotation sucrose gradient. WT cells expressing 
3HA-tagged Pca1p or Pca1p(degronΔ) lacking first 392 amino acids containing a degron were co-
cultured with MG132 for 2 hrs. Cycloheximide was added to the media 1 hr before collecting cells. Total 
cell lysates were prepared by glass bead disruption followed by centrifugation (300 x g, 10 min) to 
remove unbroken cells. Samples were loaded at the layer of 1.7 M sucrose density at a 0.25 to 2.3M 
gradient from the top to bottom. After centrifugation (100,000 x g, 5 hrs), the collected fractions were 
subjected to Western blotting. An aliquot was incubated with Triton X-100 (1 %) on ice for 30 min before 
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the fractionation to extract Pca1p out of the membrane. Obtained fractions were subjected to Western blot 
analyses of Pca1p and Pca1p(degronΔ) using anti-HA antibodies. Pgk1p was detected as a marker of 
fractions containing soluble proteins. C, Distribution of full-length, ubiquitinylated, and fragmented 
Pca1p species. Fractions obtained as described in B were subjected to Western blot analysis of Pca1p with 
and without treatment of deubiquitinylation enzyme. Fractions 10, 11 and 12 containing cytosolic proteins 
were pooled, deubiquitinylated (De-Ub), and then solubilized by detergent (1 % Triton X-100). Pca1p 
was immuno-precipitated using anti-HA antibodies. The samples were subjected to Western blotting 
using anti-ubiquitin (Ub) and -HA antibodies. The triangle indicates the location where full-length non-
ubiquitinylated Pca1p migrates. Results were confirmed by three or more repeats, and representative data 
is presented. 
 
FIGURE 3. Pca1p forms a complex with the proteasome at the membrane in a Doa10p dependent 
manner. Pca1p, Pca1p(degronΔ) deleting first 392 amino acids, and control empty vector were expressed 
in WT and doa10Δ strains. Two c-myc epitopes were tagged at the C-terminus of Pca1p. Cells were 
cultured with and without a cell permeable and reversible cross-linker (DTBP, 100 µg/ml) and MG132 
(20 µM) for 2 hrs. Cell lysates were obtained by Triton X-100 (1 %) solubilization of membrane fraction. 
The samples were subjected to immunoprecipitation using anti-myc antibodies. Co-immunoprecipitation 
of Pca1p with Rpn5p, a subunit of 19S regulatory particle (A, C), and α and β subunits of 20S catalytic 
core (D) was determined by Western blotting. B, Pcalp and Rpn5 levels in the input (cell lysate) and flow-
through of Pca1p immune-precipitation (IP flow-through) were compared by Western blotting. Each 
experiment was conducted twice using two independent clones, and representative data is presented. 
 
FIGURE 4. Cdc48p plays a role in Pca1p’s complex formation with the proteasome but not its poly-
ubiquitinylation. A, No significant change of protein poly-ubiquitinylation in cells expressing non-
functional Ccd48p. Pca1p tagged with triple HA epitope was expressed in a strain carrying a temperature-
sensitive cdc48-3. The cells at mid-log phase were cultured at a permissive temperature (23 oC), or shifted 
to a restrictive temperature (37 oC), for 30 min with a cell permeable and reversible cross-linker (DTBP, 
100 µg/ml) and MG132 (20 µM), a proteasome inhibitor, for 2 hrs. Membrane fractions were solubilized 
with Triton X-100 (1 %). Expression levels of Pca1p and Rpn5p and the overall ubiquitinylation status 
were determined by Western blot. B, Cdc48p-dependent physical association between Pca1p and Rpn5p, 
a subunit of 19S regulatory particle, was determined by co-immunoprecipitation. Triton X-100 (1 %) 
solubilized membrane fraction was used for immune-precipitation of Pca1p using anti-HA antibodies. Co-
immunoprecipitation of Rpn5p, a subunit of 19S regulatory particle was detected by Western blot. C, 
Poly-ubiquitinylation of Pca1p as a functional of Cdc48p activities. To determine ubiquitinylation status 
of Pca1p, the samples obtained as described in B were subjected to Western blot using anti-ubiquitin 
antibodies. To compare relative ubiquitinylation of Pca1p, five-fold amount of immune-precipitated 
Pca1p from cells cultured at 23 oC relative to those at 37 oC was loaded. Each data was confirmed by 
triplicate experiments. 
 
FIGURE 5. Formation of a complex between Pca1p and the proteasome is independent of poly-
ubiquitinylation of Pca1p. A, Significant reduction of turnover rate of Pca1p in UFD2 gene knockout 
(ufd2Δ) cells. Pca1p tagged with two c-myc epitope at the C-terminus was expressed in WT, ufd2Δ, and 
hul5Δ strains. Cycloheximide (CHX) chase and Western blot determined Pca1p levels. Protein extracts 
were prepared by glass bead disruption and detergent (1 % Triton X-100) solubilization. Pgk1p was 
probed to determine equal loading. B, Pca1p levels presented in A were quantitated (n=4). Pca1p levels 
relative to those at time 0 are presented. Asterisk indicates p<0.01. C, Defect in poly-ubiquitinylation of 
Pca1p in a ufd2Δ strain. Pca1p tagged c-myc epitope was expressed in a ufd2Δ strain. Total cell lysates 
(T) were obtained with and without co-culture with MG132 (20 µM, 2 hrs). Samples were subjected to 
separation to soluble (S) and pellet (P) fractions by centrifugation (100,000 x g for 30 min). After 
solubilization with Triton-X 100 (1 %), S and P fractions were subjected to immune-precipitation using 
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anti-myc antibodies followed by Western blotting using anti-ubiquitin (Ub) and -myc antibodies to detect 
Pca1p. D, Distribution of Pca1p species in the S and P fractions in ufd2Δ cells. Total cell lysates (T) and 
soluble (S) and pellet (P) fractions described in C were subjected to Western blot using anti-myc and -
Pgk1p antibodies. E, Formation of a complex between Pca1p and Rpn5p, a subunit of the 19S 
proteasome. After co-culturing the cells with a permeable and reversible cross-linker (DTBP, 100 µg/ml) 
and MG132, an inhibitor of proteasomal proteolytic activities, cell lysates were obtained by glass bead 
disruption and detergent solubilization. The samples were subjected to immunoprecipitation using anti-
myc antibodies. Rpn5p in the samples was detected by Western blotting using anti-Rpn5p antibodies. The 
triangle (C and D) indicates the location where full-length Pca1p migrates. Experiment (B - D) was 
conducted twice using two independent clones, and representative data is presented. 
 
FIGURE 6. Ste6*p, Hmg2p, and Cpy1*p form a complex with the proteasome at the membrane. 
Ste6*p, Hmg2p, or Cpy1*p tagged with either HA or c-myc epitope was expressed in WT control (A-C) 
doa10Δ (A) and hrd1Δ (D) cells. Cells were co-cultured with MG132 (20 µM, 2 hrs), an inhibitor of 
proteasomal proteolytic activities, and a cell permeable reversible cross-linker (DTBP, 100 µg/ml, 30 
min). Total cell lysates (T) were prepared by glass bead disruption.  Samples were subjected to separation 
of soluble (S) and membrane (P) fractions by centrifugation (100,000 x g, 30 min). Protein extracts were 
obtained by solubilizing samples with detergent (1 % Triton X-100). A, The membrane (P) fractions were 
used to determine an interaction of Ste6*p with the proteasome. HA-Ste6*p were subjected to anti-HA 
immunoprecipitation followed by Western using anti-HA and anti-Rpn5 antibodies.  B and C, Lysates of 
WT cells expressing Hmg2p-myc or Cpy1*p-myc were subjected to fractionation (S and P) followed by 
detergent solubilization. Anti-myc immunoprecipitation and Western blotting using anti-Rpn5p and -myc 
antibodies determined their physical interaction. Ubiquitinylation status was determined by probing the 
blots with anti-ubiquitin (Ub) antibodies (C, middle panel). D, Cpy1*p expressed in total cell lysate (T) 
and S and P fractions of hrd1Δ cells was detected by Western blot using anti-myc antibodies. The blots 
were also probed with antibodies against Kar2p and Pgk1p, an ER-resident protein and cytosolic protein, 
respectively. Representative figures of two or more independent experiments are presented. 
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